Burton-Faragher2018_Article_ObesityAndType-2DiabetesAsIndu.pdf (696.22 kB)
Download file

Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing

Download (696.22 kB)
journal contribution
posted on 15.08.2018, 09:51 by Dominick Burton, Richard G. A. Faragher
Cellular senescence is now considered as a major mechanism in the development and progression of various diseases and this may include metabolic diseases such as obesity and type-2 diabetes. The presence of obesity and diabetes is a major risk factor in the development of additional health conditions, such as cardiovascular disease, kidney disease and cancer. Since senescent cells can drive disease development, obesity and diabetes can potentially create an environment that accelerates cell senescence within other tissues of the body. This can consequently manifest as age-related biological impairments and secondary diseases. Cell senescence in cell types linked with obesity and diabetes, namely adipocytes and pancreatic beta cells will be explored, followed by a discussion on the role of obesity and diabetes in accelerating ageing through induction of premature cell senescence mediated by high glucose levels and oxidised low-density lipoproteins. Particular emphasis will be placed on accelerated cell senescence in endothelial progenitor cells, endothelial cells and vascular smooth muscle cells with relation to cardiovascular disease and proximal tubular cells with relation to kidney disease. A summary of the potential strategies for therapeutically targeting senescent cells for improving health is also presented.



  • Mechanical, Electrical and Manufacturing Engineering

Published in



BURTON, D.G.A. and FARAGHER, R.G.A., 2018. Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing. Biogerontology, 19(6), pp. 447–459.


Springer (© The Authors)


VoR (Version of Record)

Publisher statement

This work is made available according to the conditions of the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Full details of this licence are available at: http://creativecommons.org/licenses/ by/4.0/

Acceptance date


Publication date



This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.







Usage metrics